Hematologic- and oncologic-associated rheumatic syndromes
Alexa Meara, MD, MS
The Ohio State University Wexner Medical Center
COLUMBUS, OH, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Bernard Ng, MBBS, MSc, MMed
VA Puget Sound HCS
Seattle, WA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
A complex relationship exists between rheumatic diseases and cancer, particularly for patients with hematologic malignancies. Large granular lymphocyte (LGL) leukemia is at the intersection of chronic inflammation, lymphoproliferative disease, and autoimmunity. Pathogenesis and management of LGL in patients with rheumatic diseases will be discussed.
Speaker: Thomas Loughran, MD – University of Virginia
